amosulalol has been researched along with arotinolol in 2 studies
*arotinolol: structure given in first source; arotinolol is the (+-)-isomer [MeSH]
*arotinolol: structure given in first source; arotinolol is the (+-)-isomer [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Honda, K; Inagaki, O; Nakagawa, C; Shibasaki, M; Sudoh, K | 1 |
| Kinami, J; Maruyama, K; Nagatomo, T; Sasaki, K; Tsuchihashi, H | 1 |
2 other study(ies) available for amosulalol and arotinolol
| Article | Year |
|---|---|
Characterization of the adrenoceptor antagonistic and antihypertensive activity of oral amosulalol, a combined alpha- and beta-adrenoceptor antagonist, in hypertensive rats.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Decerebrate State; Desoxycorticosterone; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanolamines; Heart Rate; Hypertension; Hypertension, Renal; Labetalol; Male; Propanolamines; Rats; Rats, Inbred SHR | 1994 |
Nipradilol displays a unique pharmacological profile of affinities for the different alpha 1-adrenoceptor subtypes.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Binding, Competitive; Ethanolamines; Guinea Pigs; In Vitro Techniques; Isomerism; Labetalol; Male; Prazosin; Propanolamines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha | 1993 |